Release Date: 29/01/10 15:04 Summary: Quarterly Activities Report and Appendix 5B Price Sensitive: Yes Download Document 243.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%